CBMG
Cellular Biomedicine Group, Inc.
CBMG
CBMG
Delisted
CBMG was delisted on the 19th of February, 2021.
38 hedge funds and large institutions have $29.4M invested in Cellular Biomedicine Group, Inc. in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $312K
Holders
38
Holding in Top 10
–
Calls
$1K
Puts
$312K
Top Buyers
| 1 | +$1.5M | |
| 2 | +$820K | |
| 3 | +$527K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$352K |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$218K |
Top Sellers
| 1 | -$182K | |
| 2 | -$105K | |
| 3 | -$64.6K | |
| 4 |
Bank of New York Mellon
New York
|
-$36.9K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$6.3K |